Stockscreener 앱 받기
2.25
7.14%
0.15
Cocrystal Pharma Inc 주식(COCP)의 최신 뉴스
US Penny Stocks To Watch In December 2024 - Yahoo Finance
Detection of Hydrogen Atoms Using Only 3D ED/MicroED and Contribution to Structure Determining Salts or Cocrystals - ACS Publications
Cocrystal Pharma (FRA:8CC) Price-to-Operating-Cash-Flow : (As of Dec. 04, 2024) - GuruFocus.com
Influenza Pipeline Therapeutics Assessment Report 2024 (Updated) - openPR
Hepatitis C Virus Infection Pipeline Forecast 2024: FDA - openPR
Cocrystal Pharma (STU:8CC) Earnings Yield % : N/A% (As of Nov. 26, 2024) - GuruFocus.com
Cocrystal Pharma (STU:8CC) 14-Day RSI : 67.70 (As of Nov. 20, 2024) - GuruFocus.com
Cocrystal Pharma (STU:8CC) GF Value Rank : 10 (As of Nov. 20, 2024) - GuruFocus.com
November 2024 US Exchange Standouts: Promising Penny Stocks - Yahoo Finance
Cocrystal Pharma (STU:8CC) 3-Year EPS without NRI Growth Ra - GuruFocus.com
Cocrystal Pharma Reports Third Quarter 2024 Financial Results and Provides Updates on its Antiviral Drug-Development Programs - The Manila Times
Cocrystal Pharma Advances Clinical Trials Despite $4.9M Q3 Loss, Key Results Expected | COCP Stock News - StockTitan
Cocrystal Pharma Advances Antiviral Drug Development - TipRanks
Cocrystal Pharma's Co-CEOs Highlight Pioneering Approach to Antiviral Drug Candidates Targeting Influenza and Coronaviruses as Fall Flu and COVID Season Begins - The Manila Times
Autonomix Medical, Inc. Reports New Positive Topline Results from First 15 Patients' 7-Day Data Highlighting Significant Impact on Treatment of Pancreatic Cancer Pain with Maintained Pain Reduction - The Manila Times
Here's Why We're Watching Cocrystal Pharma's (NASDAQ:COCP) Cash Burn Situation - Yahoo Finance
Pharmaceutical Grade Hydroxytyrosol Market Poised for Growth - openPR
Innovative Approaches to Antiviral Drug Development - iHeartRadio
Influenza Pipeline Therapeutics, Assessment, Companies, Products, Unmet Needs, Market Drivers and Barriers - openPR
Seasonal Influenza Treatment Market Size, Treatment Drugs, and Companies 2024 - openPR
Cocrystal Pharma execs get pay raise and stock grants By Investing.com - Investing.com Canada
Cocrystal Pharma execs get pay raise and stock grants - Investing.com India
Cocrystal Pharma Boosts Executive and Director Compensation - TipRanks
Mira Pharmaceuticals (NASDAQ:MIRA) Stock Quotes, Forecast and News Summary - Benzinga
Cocrystal Pharma commences next phase of antiviral study - Investing.com
Cocrystal Pharma commences next phase of antiviral study By Investing.com - Investing.com Canada
Cocrystal Pharma Advances Oral Pan-Viral Protease Inhibitor CDI-988 into Phase 1 Multiple-Ascending Dose Cohorts - The Manila Times
Cocrystal Pharma Advances Oral Pan-Viral Protease Inhibitor CDI-988 into Phase 1 Multiple-Ascending Dose - EIN News
Seasonal Influenza Treatment Market Size in the 7MM was ~USD 9177 million in 2023, estimated DelveInsight - openPR
Corover Secures $4 Mn In Series A Funding Led By Venture Catalysts - BW Disrupt
K2 Principal Fund L.P. Takes $1.17 Million Position in CSLM Acquisition Corp. (NASDAQ:CSLM) - Defense World
Coherent Corp (COHR) rating reiterates by Needham - Knox Daily
Farallon Capital Management LLC Decreases Position in Cogent Biosciences, Inc. (NASDAQ:COGT) - Defense World
Corcel shares drop as explorer raise funds and ups exposure in Angola - Proactive Investors USA
Cogent Communications Holdings, Inc. (NASDAQ:CCOI) Receives Consensus Rating of "Hold" from Analysts - MarketBeat
Corcel PLC Bolsters Angola Position with Increased Stake and Funding - TipRanks
Corcel (LON:CRCL) Trading 2.6% Higher - Defense World
Cogent Biosciences, Inc. (NASDAQ:COGT) Shares Purchased by Rhumbline Advisers - Defense World
Bearish block trade of CSPC PHARMA(01093) 768K shares at $4.94, $3.794M turnover - AASTOCKS.com
CorVel Co. (NASDAQ:CRVL) Shares Acquired by Kayne Anderson Rudnick Investment Management LLC - MarketBeat
Coherent (COHR) Soars 6.3%: Is Further Upside Left in the Stock? - Yahoo Finance
Momentum Is Driving Corning Stock Higher (NYSE:GLW) - Seeking Alpha
Corbus stock reiterates Outperform rating despite trial data - Investing.com
Cosmic CRF shares hit 5% upper circuit on Rs 127-crore order win; details - Business Standard
Coherent Corp (COHR)’s Market Momentum: Closing Strong at 80.98, Up 3.93 - The Dwinnex
Corning’s stock rises as it sticks to Q3 profit view - MarketWatch
COHR’s Wild Ride: Up 82.75% – What’s Next for COHR? - The InvestChronicle
Cogent Biosciences (NASDAQ:COGT) Stock Price Up 4.1% - Defense World
CorriXR Therapeutics Appoints Jill Castilla to Its Board of Directors - Morningstar
Commonwealth Equity Services LLC Has $996,000 Holdings in Compass Diversified (NYSE:CODI) - Defense World
Examining the Potential Price Growth of CoreCivic Inc (CXW) - Knox Daily
Coherent (NYSE:COHR) delivers shareholders stellar 135% return over 1 year, surging 6.3% in the last week alone - Yahoo Finance
Prepare Yourself for Liftoff: Coherent Corp (COHR) - SETE News
Coherent Corp (COHR) receives a Buy rating from Needham - Knox Daily
Hollyland Cosmo C2 Wireless Video System First Look - Newsshooter
State of New Jersey Common Pension Fund D Lowers Stock Holdings in Sea Limited (NYSE:SE) - Defense World
LPL Financial LLC Has $46.81 Million Stake in iShares Fallen Angels USD Bond ETF (NASDAQ:FALN) - Defense World
CoreCivic Inc [CXW] stock for 106,240 USD was sold by Carter, Cole G. - Knox Daily
Influenza Pipeline Drugs 2024 | Moderna, SAB Biotherapeutics, ENA Respiratory Pty Ltd, Codagenix, AlloVir, Osivax, CureVac AG - Barchart
Titan Pharma (NASDAQ:TTNP) Stock Quotes, Forecast and News Summary - Benzinga
Cocrystal Pharma (NASDAQ:COCP) PT Lowered to $7.00 at HC Wainwright - Defense World
2.88%
2.65%
자본화:
|
볼륨(24시간):